Phase 1 Dose Escalation Trial of Total Marrow and Lymphoid Irradiation (TMLI) Using Helical Tomotherapy Combined With Etoposide (VP16) and Cyclophosphamide (CY) in Patients With Refractory Acute Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation (alloHCT)

✍ Scribed by Wong, J.Y.; Stein, A.; Palmer, J.M.; Liu, A.; O'Donnell, M.; Schultheiss, T.; Radany, E.; Snyder, D.S.; Tsai, N.; Parker, P.; Farol, L.; Spielberger, R.; Sahebi, F.; Murata-Collins, J.; Senitzer, D.; Forman, S.

• Book ID: 127190123
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 52 KB
• Volume: 90
• Category: Article
• ISSN: 0360-3016
• DOI: 10.1016/j.ijrobp.2014.05.2002